# Editas Medicine, Inc.: Form 8-K, filed Feb 28, 2024

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2024-02-28
- Accepted by EDGAR: Feb 28, 2024, 07:06 ET
- Period: 2024-02-28
- Accession: 0001650664-24-000006
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000006/edit-20240228.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000165066424000006/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000165066424000006/edit-20240228.htm

Filed Feb 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001650664-24-000006. Last ingested by Listed: Nov 6, 2026, 17:42 ET. No prices; not investment advice.